Vladyslav Dovhalyuk

Mr. Vladyslav Dovhalyuk

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2023 in Chemical Science
Verified
Journal Article
Open access
PDF file
AKAmanpreet Kaur
Amanpreet Kaur
WLWeifeng Lin
Weifeng Lin
VDVladyslav Dovhalyuk
Vladyslav Dovhalyuk
LDLéna Driutti
Léna Driutti
MMMaria Letizia Di Martino
Maria Letizia Di Martino
Daniel GlobischDaniel Globisch
Daniel Globisch
Thiol-containing metabolites in all organisms are involved in the regulation of diverse biological processes. We have developed a new method comprising bicyclobutane for chemoselective capturing and mass spectrometric analysis of this compound class.

17 April 2025 in United European Gastroenterology Journal
Verified
Journal Article
Open access
VDVladyslav Dovhalyuk
Vladyslav Dovhalyuk
FYFan Yang
Fan Yang
SNSara Nikolic
Sara Nikolic
MVMiroslav Vujasinovic
Miroslav Vujasinovic
MLMatthias Löhr
Matthias Löhr
Daniel GlobischDaniel Globisch
Daniel Globisch
Background: Chronic pancreatitis is a risk factor for pancreatic cancer. Autoimmune pancreatitis is a unique form of chronic pancreatitis that is primarily characterized by its immune mediate etiology, clinically resembling pancreatic cancer, yet uniquely responsive to steroid treatment.Objective: Early and accurate diagnosis of autoimmune pancreatitis is vital for effective treatment and patient prognosis, for which new diagnostic tools are urgently required. Gut microbiota dysbiosis has been identified to correlate with the development of pancreatic diseases, which provides new opportunities for the discovery of disease biomarkers.Methods: We utilized a mass spectrometric global metabolomics investigation of patient autoimmune pancreatitis and chronic pancreatitis fecal samples, investigating microbiome, dietary and human metabolism.Results: We discovered a series of newly identified metabolic signatures between both patient groups including enterolactone, 4‐guanidinobutanoic acid, and methylthioadenosine sulfoxide. Additionally, the analysis revealed significant differences in several metabolic pathways such as fatty acids, alkaloids, amino acids and peptides.Conclusion: Our observations provide novel insights into important metabolic human pathways and microbiome‐derived metabolites to distinguish autoimmune pancreatitis from chronic pancreatitis. These findings reveal systemic metabolic responses and the identified metabolites may be developed into potential biomarkers for future diagnosis to distinguish between autoimmune pancreatitis and chronic pancreatitis.

29 November 2023 in Proceedings
Verified
Conference Paper
Open access
PDF file
VDVladyslav Dovhalyuk
Vladyslav Dovhalyuk
AKAmanpreet Kaur
Amanpreet Kaur
WLWeifeng Lin
Weifeng Lin
ITIoanna Tsiara
Ioanna Tsiara
SMSydney Mwasambu
Sydney Mwasambu
Daniel GlobischDaniel Globisch
Daniel Globisch
The impact of the gut microbiota on human physiology through their vast metabolic activities has surfaced as a remarkable scientific discovery over the past decade

3 June 2026 in The Analyst
Verified
Journal Article
Open access
PDF file
VDVladyslav Dovhalyuk
Vladyslav Dovhalyuk
Daniel GlobischDaniel Globisch
Daniel Globisch
In this study, the impact of fecal sample collection, storage, and preparation of the metabolome was investigated. We have systematically evaluated these effects for storage stability across different stages of sample preparation protocols.